Transcription of Public Assessment Report Decentralised Procedure - …
{{id}} {{{paragraph}}}
Example: barber
Public Assessment Report Decentralised Procedure - …
PAR sildenafil 25 mg, 50 mg and 100 mg film-coated tablets PL 34771/0143-5; UK/H/4673/001-3/DC 1 Public Assessment Report Decentralised Procedure sildenafil 25 mg film-coated tablets sildenafil 50 mg film-coated Tablets sildenafil 100 mg film-coated tablets UK/H/4673/001-3/DC UK licence numbers: PL 34771/0143-5 Macleods Pharma UK Limited PAR sildenafil 25 mg, 50 mg and 100 mg film-coated tablets PL 34771/0143-5; UK/H/4673/001-3/DC 2 LAY SUMMARY On 02 July 2012, the MHRA granted Macleods Pharma UK Limited Marketing Authorisations (licences) for the medicinal products, sildenafil 25 mg, 50 mg and 100 mg film-coated tablets (PL 34771/0143-5).
PAR Sildenafil 25 mg, 50 mg and 100 mg film-coated tablets PL 34771/0143-5; UK/H/4673/001-3/DC 1 Public Assessment Report Decentralised Procedure
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
Effect of sildenafil citrate on the cardiovascular, Sildenafil Citrate, Cardiovascular, Effect of sildenafil citrate on the cardiovascular system, MATERIAL SAFETY DATA, Pfizer, MATERIAL SAFETY DATA SHEET, PRODUCT CHARACTERISTICS, Sildenafil, Scientific discussion, Scientific, Zealand Data Sheet 1 PRODUCT NAME